A Systematic Review of the Use of Blogs and Vlogs as Self-Expressors for People with Serious and Common Mental Illness.

Psychiatr QMay 10, 2025 (epub)
Clinical ResearchPsychiatryOpen access

Iris María Muñoz-Del-Pino, José Antonio Matías-García, Francisco Javier Saavedra-Macías

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined empirical studies of blogs and vlogs used by people with serious or common mental illness. Following PRISMA guidelines, the authors searched four databases and included 18 peer-reviewed English-language studies published from 2014 to 2024. The narratives were generally first-person and addressed stigma, treatment barriers and symptom self-management. Reported benefits included support networks, less social isolation and empowerment, while identified risks included potential employment discrimination and emotional vulnerability to negative comments. The review relates these experiences to personal recovery and calls for further research, including on cross-cultural experiences.

Key findings

  • Eighteen studies met the review’s inclusion criteria.
  • Blogs and vlogs commonly featured first-person narratives about stigma, barriers to treatment and symptom self-management.
  • Reported benefits included support networks, reduced social isolation and empowerment.
  • Identified risks included possible employment discrimination and emotional vulnerability to negative comments.

Why it matters

Online illness narratives may offer people with mental illness avenues for expression, connection and empowerment, while also exposing them to potential harms. Recognising both sides can inform understanding of how digital media may relate to personal recovery and help guide research into ways to support beneficial use.

What to keep in mind

The review included only English-language studies published in peer-reviewed journals, and the abstract identifies a need for further research on cross-cultural experiences.

Source

Published in Psychiatr Q. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.